On the public citation graph

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

0 signed · 789 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2013.276300openalex-snapshot

Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis

inferredcites →https://doi.org/10.1002/hep.23258openalex-snapshot

Alcoholic Liver Disease

inferredcites →https://doi.org/10.1007/s10620-012-2097-4openalex-snapshot

Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial)

inferredcites →https://doi.org/10.1016/0016-5085(78)90401-8openalex-snapshot

Corticosteroid therapy of alcoholic hepatitis

inferredcites →https://doi.org/10.1016/j.jhep.2011.12.028openalex-snapshot

Is a liver biopsy necessary in alcoholic hepatitis?

inferredcites →https://doi.org/10.1016/j.jhep.2012.02.010openalex-snapshot

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

inferredcites →https://doi.org/10.1016/j.jhep.2014.05.014openalex-snapshot

Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: A randomised, non-inferiority, open trial

inferredcites →https://doi.org/10.1053/gast.1996.v110.pm8964410openalex-snapshot

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

inferredcites →https://doi.org/10.1053/gast.2000.20189openalex-snapshot

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial

inferredcites →https://doi.org/10.1053/j.gastro.2009.04.062openalex-snapshot

Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor

inferredcites →https://doi.org/10.1056/nejm198412063112302openalex-snapshot

Short-Term and Long-Term Survival in Patients with Alcoholic Hepatitis Treated with Oxandrolone and Prednisolone

inferredcites →https://doi.org/10.1056/nejm199202203260802openalex-snapshot

A Randomized Trial of Prednisolone in Patients with Severe Alcoholic Hepatitis

inferredcites →https://doi.org/10.1056/nejmoa1101214openalex-snapshot

Glucocorticoids plusN-Acetylcysteine in Severe Alcoholic Hepatitis

inferredcites →https://doi.org/10.1056/nejmra0805786openalex-snapshot

Alcoholic Hepatitis

inferredcites →https://doi.org/10.1111/apt.12279openalex-snapshot

Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis

inferredcites →https://doi.org/10.1111/apt.12427openalex-snapshot

Determinants of long-term outcome in severe alcoholic hepatitis

inferredcites →https://doi.org/10.1111/j.1365-2036.2008.03685.xopenalex-snapshot

Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato‐Biliary Group systematic review with meta‐analyses and trial sequential analyses of randomized clinical trials

inferredcites →https://doi.org/10.1136/gut.2010.224097openalex-snapshot

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data

inferredcites →https://doi.org/10.1186/1745-6215-14-262openalex-snapshot

Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial

inferredcites →https://doi.org/10.3748/wjg.15.1613openalex-snapshot

Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial

inferredcites →https://doi.org/10.4292/wjgpt.v4.i2.16openalex-snapshot

Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3649412openalex-extracted

Early Diagnosis and Early Management Proposal in Dengue Infection: New Normal to Applied Strategy for COVID-19 Infection

inferred← citeshttps://doi.org/10.2139/ssrn.4676966openalex-extracted

Identification of Alcoholic Hepatitis-Related and Mesenchymal Stem Cell Therapy Target Genes

inferred← citeshttps://doi.org/10.1001/jama.2021.7683openalex-snapshot

Diagnosis and Treatment of Alcohol-Associated Liver Disease

inferred← citeshttps://doi.org/10.1001/jama.2023.1729openalex-snapshot

The Role of Prophylactic Antibiotics for Patients With Severe Alcohol-Related Hepatitis

inferred← citeshttps://doi.org/10.1001/jama.2023.4902openalex-snapshot

Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis

inferred← citeshttps://doi.org/10.1001/jamasurg.2021.3748openalex-snapshot

Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease

inferred← citeshttps://doi.org/10.1002/14651858.cd001511.pub3openalex-snapshot

Glucocorticosteroids for people with alcoholic hepatitis

inferred← citeshttps://doi.org/10.1002/14651858.cd001511.pub4openalex-snapshot

Glucocorticosteroids for people with alcoholic hepatitis

inferred← citeshttps://doi.org/10.1002/14651858.cd011646.pub2openalex-snapshot

Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease)

inferred← citeshttps://doi.org/10.1002/9781119235170.ch14openalex-snapshot

Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease

inferred← citeshttps://doi.org/10.1002/9781119237662.ch25openalex-snapshot

Alcohol and the Liver

inferred← citeshttps://doi.org/10.1002/9781119251316.ch18openalex-snapshot

Acute‐on‐Chronic Liver Failure

inferred← citeshttps://doi.org/10.1002/9781119251316.ch26openalex-snapshot

Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1002/9781119515777.ch37openalex-snapshot

Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1002/9781394322121.ch5openalex-snapshot

Gastroenterology

inferred← citeshttps://doi.org/10.1002/advs.201801585openalex-snapshot

Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases

inferred← citeshttps://doi.org/10.1002/cld.1092openalex-snapshot

Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1002/cld.1164openalex-snapshot

Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1002/cld.1259openalex-snapshot

The evolving paradigm of alcohol-associated hepatitis and liver transplantation

inferred← citeshttps://doi.org/10.1002/cld.1265openalex-snapshot

Prospective clinical trials and novel therapies in the medical management of severe alcohol‐associated hepatitis

inferred← citeshttps://doi.org/10.1002/cld.629openalex-snapshot

Transplantation for acute alcoholic hepatitis

inferred← citeshttps://doi.org/10.1002/cld.693openalex-snapshot

Early liver transplantation for severe alcoholic hepatitis

inferred← citeshttps://doi.org/10.1002/cld.730openalex-snapshot

Con: The Abstinence Period Should Be Determined on a Case‐by‐Case Basis

inferred← citeshttps://doi.org/10.1002/cld.736openalex-snapshot

Steroids for Severe Alcoholic Hepatitis: More Risk Than Reward?

inferred← citeshttps://doi.org/10.1002/cld.792openalex-snapshot

New Prospects for Medical Management of Acute Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1002/cld.854openalex-snapshot

Behavioral Treatment for Patients With Alcohol‐Related Liver Disease: A Primer for Hepatologists

inferred← citeshttps://doi.org/10.1002/hep.28530openalex-snapshot

Alcoholic hepatitis: Translational approaches to develop targeted therapies

inferred← citeshttps://doi.org/10.1002/hep.29080openalex-snapshot

A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis

inferred← citeshttps://doi.org/10.1002/hep.29240openalex-snapshot

Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study

inferred← citeshttps://doi.org/10.1002/hep.29338openalex-snapshot

Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long‐term survival

inferred← citeshttps://doi.org/10.1002/hep.29623openalex-snapshot

The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis

inferred← citeshttps://doi.org/10.1002/hep.29645openalex-snapshot

Pyroptosis by caspase11/4‐gasdermin‐D pathway in alcoholic hepatitis in mice and patients

inferred← citeshttps://doi.org/10.1002/hep.29825openalex-snapshot

People who survive an episode of severe alcoholic hepatitis should be advised to maintain total abstinence from alcohol

inferred← citeshttps://doi.org/10.1002/hep.30516openalex-snapshot

Efficacy of Granulocyte Colony‐stimulating Factor in the Management of Steroid‐Nonresponsive Severe Alcoholic Hepatitis: A Double‐Blind Randomized Controlled Trial

inferred← citeshttps://doi.org/10.1002/hep.30587openalex-snapshot

A Call to Standardize Definitions, Data Collection, and Outcome Assessment to Improve Care in Alcohol‐Related Liver Disease

inferred← citeshttps://doi.org/10.1002/hep.30866openalex-snapshot

Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases

inferred← citeshttps://doi.org/10.1002/hep.31010openalex-snapshot

Letter to the Editor: Glucocorticosteroids for Alcohol‐Associated Hepatitis

inferred← citeshttps://doi.org/10.1002/hep.31046openalex-snapshot

An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis

inferred← citeshttps://doi.org/10.1002/hep.31459openalex-snapshot

Intestinal Virome in Patients With Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1002/hep.31539openalex-snapshot

Measuring the Alcohol in Alcohol‐Associated Liver Disease: Choices and Challenges for Clinical Research

inferred← citeshttps://doi.org/10.1002/hep.31984openalex-snapshot

Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol‐Associated Liver Disease

inferred← citeshttps://doi.org/10.1002/hep.31994openalex-snapshot

Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol‐Associated Hepatitis

inferred← citeshttps://doi.org/10.1002/hep.32057openalex-snapshot

REPLY:

inferred← citeshttps://doi.org/10.1002/hep.32143openalex-snapshot

Research methodologies to address clinical unmet needs and challenges in alcohol‐associated liver disease

inferred← citeshttps://doi.org/10.1002/hep.32203openalex-snapshot

Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol‐associated hepatitis

inferred← citeshttps://doi.org/10.1002/hep.32478openalex-snapshot

IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis

inferred← citeshttps://doi.org/10.1002/hep.32523openalex-snapshot

We need a new approach to clinical trials in alcohol‐associated hepatitis: Is there a lesson in RECOVERY?

inferred← citeshttps://doi.org/10.1002/hep.32645openalex-snapshot

inferred← citeshttps://doi.org/10.1002/hep4.1176openalex-snapshot

Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome

inferred← citeshttps://doi.org/10.1002/hep4.1191openalex-snapshot

Can we reliably predict response to corticosteroid treatment in severe alcoholic hepatitis?

inferred← citeshttps://doi.org/10.1002/hep4.1438openalex-snapshot

Dysregulated Lipid Transport Proteins Correlate With Pathogenesis and Outcome in Severe Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1002/hep4.1440openalex-snapshot

Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1002/hep4.1786openalex-snapshot

Risk Prediction of Nosocomial and Posthospital Discharge Infections in Alcohol‐Associated Hepatitis

inferred← citeshttps://doi.org/10.1002/jbt.23502openalex-snapshot

Molecular mechanisms of alcohol's effects on the human body: A review and update

inferred← citeshttps://doi.org/10.1002/jgh3.12707openalex-snapshot

Elevated blood monocyte counts in alcohol‐associated hepatitis

inferred← citeshttps://doi.org/10.1002/jgh3.12891openalex-snapshot

Assessment of immune function and prediction of survival and infection in patients with severe alcoholic hepatitis: An exploratory study

inferred← citeshttps://doi.org/10.1002/jgh3.70007openalex-snapshot

Impact of fecal microbiota transplantation in severe alcoholic hepatitis: A systematic review and meta‐analysis

inferred← citeshttps://doi.org/10.1002/lipd.12033openalex-snapshot

Noncholesterol Sterols as Surrogate Markers in Patients with Severe Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1002/lt.24208openalex-snapshot

Liver transplantation for alcoholic hepatitis: A survey of liver transplant centers

inferred← citeshttps://doi.org/10.1002/lt.24986openalex-snapshot

Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial

inferred← citeshttps://doi.org/10.1002/lt.25020openalex-snapshot

Extracorporeal liver assist device for alcoholic hepatitis: A potential silver lining?

inferred← citeshttps://doi.org/10.1002/lt.25285openalex-snapshot

Survey of Liver Transplantation Practices for Severe Acute Alcoholic Hepatitis†

inferred← citeshttps://doi.org/10.1002/lt.25328openalex-snapshot

A Validated Score Predicts Acute Kidney Injury and Survival in Patients With Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1002/lt.25384openalex-snapshot

Con: The Unclear Benefit of Albumin

inferred← citeshttps://doi.org/10.1002/lt.25600openalex-snapshot

Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol‐Associated Liver Disease

inferred← citeshttps://doi.org/10.1002/lt.26282openalex-snapshot

The Rush to Early Liver Transplantation for Alcoholic Hepatitis—Potential Financial Implications

inferred← citeshttps://doi.org/10.1002/mco2.70086openalex-snapshot

Therapeutic potential of nicotinamide and ABT263 in alcohol‐associated liver disease through targeting cellular senescence

inferred← citeshttps://doi.org/10.1002/mco2.70256openalex-snapshot

Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications

inferred← citeshttps://doi.org/10.1002/prp2.631openalex-snapshot

Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients

inferred← citeshttps://doi.org/10.1002/sim.70684openalex-snapshot

A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies

inferred← citeshttps://doi.org/10.1002/ueg2.12065openalex-snapshot

Severe alcoholic hepatitis: Jumping from the frying pan into the fire

inferred← citeshttps://doi.org/10.1007/7854_2024_478openalex-snapshot

Role of the Microbiome and the Gut-Brain Axis in Alcohol Use Disorder: Potential Implication for Treatment Development

inferred← citeshttps://doi.org/10.1007/978-1-4939-8628-6_7openalex-snapshot

Acute Kidney Injury and Liver Disease: Incidence, Pathophysiology, Prevention/Treatment, and Outcomes

inferred← citeshttps://doi.org/10.1007/978-3-030-24490-3_10openalex-snapshot

Acute Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/978-3-030-24490-3_11openalex-snapshot

Acute on Chronic Liver Failure

inferred← citeshttps://doi.org/10.1007/978-3-030-26710-0_75openalex-snapshot

The ICU Management of Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1007/978-3-030-50983-5_14openalex-snapshot

Alcoholic Hepatitis and Alcohol-Related Acute on Chronic Liver Failure

inferred← citeshttps://doi.org/10.1007/978-3-030-51709-0_20openalex-snapshot

Alcohol-Associated Liver Disease

inferred← citeshttps://doi.org/10.1007/978-3-030-82930-8_4openalex-snapshot

Acute Alcoholic Hepatitis: Indication for Early Liver Transplantation

inferred← citeshttps://doi.org/10.1007/978-3-030-84752-4_11openalex-snapshot

Alcohol Related Liver Disease

inferred← citeshttps://doi.org/10.1007/978-3-031-10012-3_4openalex-snapshot

Liver Decompensation and Acute on Chronic Liver Failure

inferred← citeshttps://doi.org/10.1007/978-3-031-19564-8_10openalex-snapshot

Fecal Microbiota Transplantation in Diseases Not Associated with Clostridium difficile: Current Status and Future Therapeutic Option

inferred← citeshttps://doi.org/10.1007/978-3-031-32483-3_47openalex-snapshot

Acute Liver Failure Due to Alcohol Intoxication—Therapeutic Options

inferred← citeshttps://doi.org/10.1007/978-3-031-32483-3_64openalex-snapshot

Pathophysiology of Alcoholic Hepatitis: Emerging Role of Enhanced Red Blood Cell Turnover

inferred← citeshttps://doi.org/10.1007/978-3-031-32483-3_65openalex-snapshot

Diagnosis and Staging of Disease-Severity in Symptomatic Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/978-3-031-32483-3_66openalex-snapshot

Management of Severe Forms of Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/978-3-031-32483-3_67openalex-snapshot

Mechanisms of Recovery from and Strategies for Survival of Severe Alcoholic Hepatitis and ACLF

inferred← citeshttps://doi.org/10.1007/978-3-031-32483-3_68openalex-snapshot

The Role of Liver Biopsy and Hepatic Venous Pressure Gradient in the Prognosis of Acute Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/978-3-031-32483-3_7openalex-snapshot

Alcohol and Mortality: First Preliminary Lessons from a Prospective 15 Year Follow-Up Study

inferred← citeshttps://doi.org/10.1007/978-3-032-12399-2_9openalex-snapshot

Gastroenterology

inferred← citeshttps://doi.org/10.1007/978-3-319-20538-0_15openalex-snapshot

Treatment of Alcoholic Liver Disease Including Emerging Therapies, Novel Targets, and Liver Transplantation

inferred← citeshttps://doi.org/10.1007/978-3-319-30103-7_13openalex-snapshot

Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1007/978-3-319-43126-0_2openalex-snapshot

Liver Decompensation and Acute on Chronic Liver Failure

inferred← citeshttps://doi.org/10.1007/978-3-319-43126-0_6openalex-snapshot

Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/978-3-319-43341-7_69openalex-snapshot

ICU Management of the Patient with Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1007/978-3-319-53298-1_19openalex-snapshot

Androgen Therapy for Hypogonadism in Men with Chronic Illnesses

inferred← citeshttps://doi.org/10.1007/978-3-319-98506-0_2openalex-snapshot

Acute Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/978-3-642-41620-0_159openalex-snapshot

Akutes Leberversagen

inferred← citeshttps://doi.org/10.1007/978-3-642-54675-4_74-2openalex-snapshot

Intensivtherapie bei akutem und chronischem Leberversagen

inferred← citeshttps://doi.org/10.1007/978-3-642-54676-1_159-1openalex-snapshot

Akutes Leberversagen

inferred← citeshttps://doi.org/10.1007/978-3-662-63677-0_3openalex-snapshot

Behandlung von riskantem, schädlichem und abhängigem Alkoholgebrauch

inferred← citeshttps://doi.org/10.1007/978-3-662-68699-7_74openalex-snapshot

Intensivtherapie bei akutem und chronischem Leberversagen

inferred← citeshttps://doi.org/10.1007/978-981-95-2624-6_12openalex-snapshot

Alcohol-Related Liver Disease

inferred← citeshttps://doi.org/10.1007/s00018-022-04509-6openalex-snapshot

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

inferred← citeshttps://doi.org/10.1007/s00063-017-0263-3openalex-snapshot

Das akut-auf-chronische Leberversagen als diagnostische und therapeutische Herausforderung der Intensivmedizin

inferred← citeshttps://doi.org/10.1007/s00063-019-00613-xopenalex-snapshot

Behandlungsstrategien des akut-auf-chronischen Leberversagens

inferred← citeshttps://doi.org/10.1007/s00423-018-1720-zopenalex-snapshot

Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis

inferred← citeshttps://doi.org/10.1007/s00535-016-1287-9openalex-snapshot

Sequential therapy consisting of glucocorticoid infusions followed by granulocyte–monocyte absorptive apheresis in patients with severe alcoholic hepatitis

inferred← citeshttps://doi.org/10.1007/s00535-017-1336-zopenalex-snapshot

Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study

inferred← citeshttps://doi.org/10.1007/s10544-022-00622-2openalex-snapshot

The protective effect of puerarin-loaded mesoporous silicon nanoparticles on alcoholic hepatitis through mTOR-mediated autophagy pathway

inferred← citeshttps://doi.org/10.1007/s10620-015-3921-4openalex-snapshot

SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/s10620-019-05721-4openalex-snapshot

Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes

inferred← citeshttps://doi.org/10.1007/s10620-019-05759-4openalex-snapshot

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study

inferred← citeshttps://doi.org/10.1007/s10620-020-06100-0openalex-snapshot

Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction

inferred← citeshttps://doi.org/10.1007/s10620-020-06142-4openalex-snapshot

A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis

inferred← citeshttps://doi.org/10.1007/s10620-021-06864-zopenalex-snapshot

Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery

inferred← citeshttps://doi.org/10.1007/s10620-021-07140-wopenalex-snapshot

Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/s10620-024-08462-1openalex-snapshot

Racial Disparities in Alcoholic Hepatitis Hospitalizations in the United States: Trends, Outcomes, and Future Projections

inferred← citeshttps://doi.org/10.1007/s10620-024-08479-6openalex-snapshot

Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis

inferred← citeshttps://doi.org/10.1007/s10620-026-09694-zopenalex-snapshot

Increasing Liver Transplant Listings for Alcohol-Associated Hepatitis in Younger Patients with High MELD Scores and Excellent Performance Status

inferred← citeshttps://doi.org/10.1007/s11695-022-06386-1openalex-snapshot

Patients with a History of Bariatric Surgery Are 8 Years Younger at Presentation with Severe Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1007/s11739-024-03786-2openalex-snapshot

SIRS criteria versus qSOFA score in patients with severe alcohol-related hepatitis

inferred← citeshttps://doi.org/10.1007/s11894-016-0539-4openalex-snapshot

Malnutrition and Nutritional Support in Alcoholic Liver Disease: a Review

inferred← citeshttps://doi.org/10.1007/s11901-020-00504-2openalex-snapshot

The Role of Nutrition in the Pathogenesis and Treatment of Alcohol-Related Liver Disease

inferred← citeshttps://doi.org/10.1007/s11901-023-00601-yopenalex-snapshot

Portal Hypertension in Alcohol-Associated Hepatitis

inferred← citeshttps://doi.org/10.1007/s11901-025-00703-9openalex-snapshot

Alcohol-Associated Hepatitis: Translating Pathophysiology into Targeted Clinical Trials

inferred← citeshttps://doi.org/10.1007/s11901-025-00709-3openalex-snapshot

Therapeutic Options for Alcohol-Associated Hepatitis in Resource-Limited Settings

inferred← citeshttps://doi.org/10.1007/s11901-026-00738-6openalex-snapshot

Interaction of Serum Trace Elements and Vitamins in Relation to Liver Enzyme Activities in Patients With Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1007/s11938-019-00229-2openalex-snapshot

Infections in Cirrhosis

inferred← citeshttps://doi.org/10.1007/s12072-016-9768-8openalex-snapshot

Alcoholic hepatitis: should we combine old drugs for better results?

inferred← citeshttps://doi.org/10.1007/s12072-016-9770-1openalex-snapshot

Live donor liver transplantation for alcoholic hepatitis

inferred← citeshttps://doi.org/10.1007/s12072-017-9790-5openalex-snapshot

New paradigms in management of alcoholic hepatitis: a review

inferred← citeshttps://doi.org/10.1007/s12072-017-9807-0openalex-snapshot

Impact of etiological treatment on prognosis

inferred← citeshttps://doi.org/10.1007/s12072-018-9867-9openalex-snapshot

Immune checkpoint receptors: homeostatic regulators of immunity

inferred← citeshttps://doi.org/10.1007/s12072-021-10165-yopenalex-snapshot

Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis

inferred← citeshttps://doi.org/10.1007/s12072-022-10312-zopenalex-snapshot

Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial

inferred← citeshttps://doi.org/10.1007/s12072-022-10438-0openalex-snapshot

Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial

inferred← citeshttps://doi.org/10.1007/s12072-022-10463-zopenalex-snapshot

AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study

inferred← citeshttps://doi.org/10.1007/s12072-023-10525-wopenalex-snapshot

Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark?

inferred← citeshttps://doi.org/10.1007/s12328-024-01988-xopenalex-snapshot

Case of severe alcoholic hepatitis following acute pancreatitis

inferred← citeshttps://doi.org/10.1007/s12664-018-0827-zopenalex-snapshot

Alcohol-related acute-on-chronic liver failure—Comparison of various prognostic scores in predicting outcome

inferred← citeshttps://doi.org/10.1007/s12664-018-0842-0openalex-snapshot

Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India

inferred← citeshttps://doi.org/10.1007/s12664-018-0859-4openalex-snapshot

Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis

inferred← citeshttps://doi.org/10.1007/s12664-024-01569-3openalex-snapshot

Centrifugal technique of plasma exchange and low-dose steroid to treat very severe alcoholic hepatitis patients: A retrospective analysis

inferred← citeshttps://doi.org/10.1007/s13167-024-00381-5openalex-snapshot

3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation

inferred← citeshttps://doi.org/10.1007/s13311-019-00802-8openalex-snapshot

Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows

inferred← citeshttps://doi.org/10.1016/b978-0-12-823524-9.00004-6openalex-snapshot

Alcoholic liver disease

inferred← citeshttps://doi.org/10.1016/b978-0-323-37591-7.00017-3openalex-snapshot

Renal Failure in Cirrhosis

inferred← citeshttps://doi.org/10.1016/b978-0-323-37591-7.00021-5openalex-snapshot

Acute-on-Chronic Liver Failure

inferred← citeshttps://doi.org/10.1016/b978-0-323-37591-7.00024-0openalex-snapshot

Prevention and Management of Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1016/b978-0-323-40232-3.00119-9openalex-snapshot

Laboratory Measurement of Hepatic Function

inferred← citeshttps://doi.org/10.1016/b978-0-323-47874-8.00008-0openalex-snapshot

Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1016/b978-0-323-95262-0.00013-9openalex-snapshot

Liver Sinusoidal Cells in alcohol-associated liver disease

inferred← citeshttps://doi.org/10.1016/b978-0-323-98368-6.00012-4openalex-snapshot

Alcoholic hepatitis

inferred← citeshttps://doi.org/10.1016/b978-0-443-23571-9.00034-7openalex-snapshot

Liver transplantation: the recipient

inferred← citeshttps://doi.org/10.1016/b978-0-443-26710-9.00007-9openalex-snapshot

Acute-on-chronic liver failure

inferred← citeshttps://doi.org/10.1016/b978-0-443-26711-6.00028-7openalex-snapshot

Alcohol-associated liver disease

inferred← citeshttps://doi.org/10.1016/b978-0-7020-6697-9.00005-4openalex-snapshot

Fatty Liver Disease

inferred← citeshttps://doi.org/10.1016/b978-0-7020-8228-3.00005-3openalex-snapshot

Fatty Liver Disease

inferred← citeshttps://doi.org/10.1016/b978-2-294-77934-3.00033-0openalex-snapshot

Urgences somatiques et addictions

inferred← citeshttps://doi.org/10.1016/b978-3-437-21005-1.00051-2openalex-snapshot

Toxische Lebererkrankungen

inferred← citeshttps://doi.org/10.1016/b978-3-437-21251-2.00010-3openalex-snapshot

Leber

inferred← citeshttps://doi.org/10.1016/b978-3-437-21252-9.00011-0openalex-snapshot

Leber

inferred← citeshttps://doi.org/10.1016/b978-3-437-23847-5.00049-1openalex-snapshot

Toxische Lebererkrankungen

inferred← citeshttps://doi.org/10.1016/b978-3-437-42502-8.16001-2openalex-snapshot

Literaturverzeichnis

inferred← citeshttps://doi.org/10.1016/b978-84-9113-949-2.00086-xopenalex-snapshot

10.1016/b978-84-9113-949-2.00086-x

inferred← citeshttps://doi.org/10.1016/j.ajpath.2018.11.008openalex-snapshot

Dynamin-1–Like Protein Inhibition Drives Megamitochondria Formation as an Adaptive Response in Alcohol-Induced Hepatotoxicity

inferred← citeshttps://doi.org/10.1016/j.ajpath.2022.08.009openalex-snapshot

Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis

inferred← citeshttps://doi.org/10.1016/j.ajpath.2025.03.009openalex-snapshot

Current Clinical Trials for Alcohol-Associated Hepatitis

inferred← citeshttps://doi.org/10.1016/j.ajpath.2025.05.012openalex-snapshot

Microbiota in Alcohol-Associated Organ Damage

inferred← citeshttps://doi.org/10.1016/j.ajpath.2026.06.001openalex-snapshot

Unbiased Spatial Proteomics Uncovers Hepatic in Situ Regulation in Alcohol-Associated Hepatitis

inferred← citeshttps://doi.org/10.1016/j.alcohol.2021.05.003openalex-snapshot

Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder

inferred← citeshttps://doi.org/10.1016/j.alcohol.2024.06.006openalex-snapshot

Risk of mortality among patients with alcohol-associated hepatitis in the US from 2007 to 2021

inferred← citeshttps://doi.org/10.1016/j.amjmed.2016.10.004openalex-snapshot

Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease

inferred← citeshttps://doi.org/10.1016/j.amjmed.2019.09.025openalex-snapshot

I Awoke With a Bloody Nose: Pulmonary Tuberculosis

inferred← citeshttps://doi.org/10.1016/j.aohep.2019.04.005openalex-snapshot

Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)

inferred← citeshttps://doi.org/10.1016/j.aohep.2020.04.011openalex-snapshot

Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis

inferred← citeshttps://doi.org/10.1016/j.aohep.2023.101098openalex-snapshot

Early living donor liver transplantation for alcohol-associated hepatitis

inferred← citeshttps://doi.org/10.1016/j.aohep.2023.101162openalex-snapshot

Alcohol-associated liver disease: Epidemiology and management

inferred← citeshttps://doi.org/10.1016/j.aohep.2024.101749openalex-snapshot

Rifaximin treatment in patients with severe alcohol-associated hepatitis: A multicenter, randomized controlled, open-label, pilot trial

inferred← citeshttps://doi.org/10.1016/j.aohep.2026.102464openalex-snapshot

Global Sociodemographic Disparities in the Severity of Alcohol-Associated Hepatitis

inferred← citeshttps://doi.org/10.1016/j.bcp.2025.117308openalex-snapshot

Isoliquiritigenin inhibits the activation of the ANXA2/STAT3 pathway by down-regulating TAGLN2, thereby alleviating alcoholic fatty liver

inferred← citeshttps://doi.org/10.1016/j.bcp.2026.118480openalex-snapshot

PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage

inferred← citeshttps://doi.org/10.1016/j.bjae.2025.06.001openalex-snapshot

Acute-on-chronic liver failure

inferred← citeshttps://doi.org/10.1016/j.bpg.2017.04.005openalex-snapshot

Reversal of liver fibrosis: From fiction to reality

inferred← citeshttps://doi.org/10.1016/j.bpg.2017.09.003openalex-snapshot

Alcohol, smoking and the liver disease patient

inferred← citeshttps://doi.org/10.1016/j.bpg.2021.101760openalex-snapshot

Use of immunosuppression in non-transplant hepatology

inferred← citeshttps://doi.org/10.1016/j.ccc.2016.02.002openalex-snapshot

The Liver in Critical Illness

inferred← citeshttps://doi.org/10.1016/j.cct.2020.106094openalex-snapshot

Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis

inferred← citeshttps://doi.org/10.1016/j.cgh.2016.08.047openalex-snapshot

Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute

inferred← citeshttps://doi.org/10.1016/j.cgh.2017.09.012openalex-snapshot

Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial

inferred← citeshttps://doi.org/10.1016/j.cgh.2017.11.022openalex-snapshot

Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1016/j.cgh.2018.01.040openalex-snapshot

Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1016/j.cgh.2018.02.002openalex-snapshot

A New Marker for Severity of Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1016/j.cgh.2019.04.048openalex-snapshot

Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1016/j.cgh.2019.11.050openalex-snapshot

Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1016/j.cgh.2021.01.042openalex-snapshot

Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis

inferred← citeshttps://doi.org/10.1016/j.cgh.2023.02.017openalex-snapshot

Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder

inferred← citeshttps://doi.org/10.1016/j.cgh.2024.07.037openalex-snapshot

Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival: A National Analysis

inferred← citeshttps://doi.org/10.1016/j.cgh.2025.05.016openalex-snapshot

Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-Analysis

showing the first 200 of 768 · page through all 768

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.